XML 50 R40.htm IDEA: XBRL DOCUMENT
v3.23.1

Net Loss Per Share Attributable to Common Stockholders (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2022
Earnings Per Share [Abstract] |
Schedule of earnings per share | The following table sets forth the calculation of basic and diluted net loss per share attributable to common stockholders during the three and six months ended June 30, 2022 and 2021:
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Net loss attributable to Nuvve common stockholders | $ | (5,494,918) |  |  | $ | (53,150,934) |  |  | $ | (10,350,727) |  |  | $ | (58,512,654) |
Weighted-average shares used to compute net loss per share attributable to Nuvve common stockholders, basic and diluted | 19,064,854 |  |  | 18,668,009 |  |  | 18,965,167 |  |  | 14,560,862 |
Net Loss per share attributable to Nuvve common stockholders, basic and diluted | $ | (0.29) |  |  | $ | (2.85) |  |  | $ | (0.55) |  |  | $ | (4.02) |
Schedule of antidilutive securities excluded from the computation of earnings per share | The following outstanding shares of common stock equivalents were excluded from the calculation of the diluted net loss per share attributable to Nuvve common stockholders because their effect would have been anti-dilutive:
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Stock options issued and outstanding | 2,688,173 |  | 2,505,711 |  |  | 2,858,756 |  | 1,792,556 |
Nonvested restricted stock issued and outstanding | 869,945 |  | 677,543 |  |  | 867,793 |  | 582,148 |
Public warrants | 2,875,000 |  | 2,875,000 |  |  | 2,875,000 |  | 1,627,060 |
Private warrants | 136,250 |  | 136,250 |  |  | 136,250 |  | 77,109 |
PIPE warrants | 1,353,750 |  | 1,353,750 |  |  | 1,353,750 |  | 766,133 |
Stonepeak and Evolve warrants | 6,000,000 |  | 2,901,099 |  |  | 6,000,000 |  | 1,450,549 |
Stonepeak and Evolve options | 5,000,000 |  | 2,417,582 |  |  | 5,000,000 |  | 1,208,791 |
Total | 18,923,118 |  | 12,866,935 |  |  | 19,091,549 |  | 7,504,346 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration